Q4 2022
Read transcript →Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$2.92
-2.18%
Mkt Cap $6.34M
Q3 2022
Read transcript →Q2 2022
Read transcript →Q1 2022
Read transcript →Q4 2021
Read transcript →Q3 2021
Read transcript →Q2 2021
Read transcript →Q1 2021
Read transcript →